Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Peer M. Portner"'
Autor:
Steven L. Lansman, Intrepid Global Pilot Study Investigators, Javed Butler, Richard N. Pierson, Joseph G. Rogers, Alan Gass, Michael K. Pasque, Peer M. Portner
Publikováno v:
Journal of the American College of Cardiology. 50:741-747
Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID TrialJoseph G. Rogers, Javed Butler, Steven L. Lansma...
Autor:
Peer M. Portner, Renee Howser, Richard N. Pierson, Javed Butler, Mario C. Deng, Carrie Geisberg, Joseph G. Rogers
Publikováno v:
The Annals of Thoracic Surgery. 81:1745-1751
Poor renal function may affect outcomes after left ventricular assist device (LVAD) placement. Conversely, LVADs may optimize circulation and improve renal function.To assess the relationship between renal function and LVAD use, changes in creatinine
Autor:
James K. Kirklin, Leslie W. Miller, Lynne W. Stevenson, Robert L. Kormos, Eric A. Rose, Mario C. Deng, James B. Young, Mehmet C. Oz, Sharon A. Hunt, Peer M. Portner, Mitchell T. Saltzberg, Jon A. Kobashigawa, Marvin A. Konstam
Publikováno v:
The Journal of Heart and Lung Transplantation. 22:365-369
Mechanical circulatory support device (MCSDs) have evolved during the past 2 decades to become accepted bridging therapy for patients with irreversible hemodynamic deterioration while awaiting cardiac transplantation. More recently, based on the resu
Publikováno v:
Journal of Cardiac Surgery. 16:267-271
The electrically powered Novacor left ventricular assist (LVAS) system was first used clinically as a bridge to transplant in 1984. The configuration has evolved to the current wearable model used clinically for the first time in 1993. In 1998, the i
Publikováno v:
The Annals of Thoracic Surgery. 71:S162-S165
The Novacor Left Ventricular Assist System (LVAS) (Novacor Corp, Oakland, CA) was initially console-based and has been available since 1993 in a wearable configuration. It has been successfully used for the past 16 years as a bridge to cardiac transp
Publikováno v:
The Annals of Thoracic Surgery. 71:205-209
Background . Cumulative experience with the Novacor wearable electric left ventricular assist system (LVAS) now exceeds 850 recipients. The pump inflow conduit (IFC) has been implicated in embolic complications. Methods . Clinical outcomes were compa
Autor:
Peer M. Portner, Klaus Affeld, Tofy Mussivand, F. A. Arabia, Victor L. Poirier, Patrick M. McCarthy, R. T. V. Kung
Publikováno v:
ASAIO Journal. 43:230-236
Autor:
Carla J. Nastala, Robert L. Kormos, Bartley P. Griffith, Stephen Winowich, Peer M. Portner, Eve A. Conner, Harvey S. Borovetz, Jeannie Gifford, John M. Pristas
Publikováno v:
ASAIO Journal. 41:M539-M543
Between September 1984 and April 1995, the Novacor left ventricular assist system (LVAS) has provided more than 13,000 days of mechanical circulatory support to cardiac transplant candidates in the United States and Europe. The duration of support of
Autor:
Philip E. Oyer, John T. Watson, Peer M. Portner, Michael J. Domanski, Bartley P. Griffith, D G Pennington, Sonja M. McKinlay
Publikováno v:
ASAIO Journal. 41:11-15
In this summary, the authors provide the background of and proposed protocol for a clinical evaluation of the safety and efficacy of the Novacor N120 left Ventricular Assist System, sponsored by the National Heart, lung, and Blood Institute. Although